Medicina
Departamento
Alejandro
Balsa Criado
Publicaciones en las que colabora con Alejandro Balsa Criado (82)
2023
-
Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis
Reumatologia Clinica, Vol. 19, Núm. 10, pp. 533-548
2021
-
HLA–B*08 Identified as the Most Prominently Associated Major Histocompatibility Complex Locus for Anti–Carbamylated Protein Antibody–Positive/Anti–Cyclic Citrullinated Peptide–Negative Rheumatoid Arthritis
Arthritis and Rheumatology, Vol. 73, Núm. 6, pp. 963-969
2020
-
"There is something you must see": breaking down the remission concept in rheumatoid arthritis from a rheumatologist's perspective
Clinical and experimental rheumatology, Vol. 38, Núm. 1, pp. 82-87
-
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease
Scientific Reports, Vol. 10, Núm. 1
-
A predominant involvement of the triple seropositive patients and others with rheumatoid factor in the association of smoking with rheumatoid arthritis
Scientific Reports, Vol. 10, Núm. 1
-
Efficacy, safety and cost-effectiveness of a web-based platform delivering the results of a biomarker-based predictive model of biotherapy response for rheumatoid arthritis patients: A protocol for a randomized multicenter single-blind active controlled clinical trial (PREDIRA)
Trials, Vol. 21, Núm. 1
-
Influence of MUC5B gene on antisynthetase syndrome
Scientific Reports, Vol. 10, Núm. 1
-
Publisher Correction: A predominant involvement of the triple seropositive patients and others with rheumatoid factor in the association of smoking with rheumatoid arthritis (Scientific Reports, (2020), 10, 1, (3355), 10.1038/s41598-020-60305-x)
Scientific Reports
2019
-
Evaluation of 12 GWAS-drawn SNPs as biomarkers of rheumatoid arthritis response to TNF inhibitors. A potential SNP association with response to etanercept
PLoS ONE, Vol. 14, Núm. 2
-
Identification of a 3′-Untranslated Genetic Variant of RARB Associated With Carotid Intima-Media Thickness in Rheumatoid Arthritis: A Genome-Wide Association Study
Arthritis and Rheumatology, Vol. 71, Núm. 3, pp. 351-360
-
Reducing or Maintaining the Dose of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis in Clinical Remission: A Randomized, Open-Label Trial
Arthritis and Rheumatology, Vol. 71, Núm. 10, pp. 1616-1625
-
Specific Association of HLA–DRB1*03 With Anti–Carbamylated Protein Antibodies in Patients With Rheumatoid Arthritis
Arthritis and Rheumatology, Vol. 71, Núm. 3, pp. 331-339
2018
-
Association of a rare variant of the TNFSF13B gene with susceptibility to Rheumatoid Arthritis and Systemic Lupus Erythematosus
Scientific Reports, Vol. 8, Núm. 1
-
Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study
The Lancet, Vol. 391, Núm. 10136, pp. 2213-2224
-
Validation study of genetic biomarkers of response to TNF inhibitors in rheumatoid arthritis
PLoS ONE, Vol. 13, Núm. 5
2017
-
A combined large-scale meta-Analysis identifies COG6 as a novel shared risk locus for rheumatoid arthritis and systemic lupus erythematosus
Annals of the Rheumatic Diseases, Vol. 76, Núm. 1, pp. 286-294
-
Exploring the remission concept in rheumatoid arthritis with patients and rheumatologists: Time for a new approach?
Clinical and Experimental Rheumatology, Vol. 35, Núm. 5, pp. 816-822
-
Influence of coronary artery disease and subclinical atherosclerosis related polymorphisms on the risk of atherosclerosis in rheumatoid arthritis
Scientific Reports, Vol. 7
-
REDOSER project: optimising biological therapy dose for rheumatoid arthritis and spondyloarthritis patients
Heliyon, Vol. 3, Núm. 11
2016
-
Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies
Arthritis and Rheumatology, Vol. 68, Núm. 9, pp. 2338-2344